In today’s session Nu Skin Enterprises, Inc. (NUS) registered an unusually high (197) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the October, 2016 call, expecting serious NUS increase. With 197 contracts traded and 4424 open interest for the Oct, 16 contract, it seems this is a quite bullish bet. The option with symbol: NUS161021C00065000 closed last at: $1.9 or 31% up. The stock decreased 0.32% or $0.21 during the last trading session, hitting $65.68. About 1.07M shares traded hands or 59.88% up from the average. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 114.43% since March 2, 2016 and is uptrending. It has outperformed by 105.19% the S&P500.
Analysts await Nu Skin Enterprises, Inc. (NYSE:NUS) to report earnings on November, 3. They expect $0.83 earnings per share, down 1.19% or $0.01 from last year’s $0.84 per share. NUS’s profit will be $47.26M for 19.78 P/E if the $0.83 EPS becomes a reality. After $0.79 actual earnings per share reported by Nu Skin Enterprises, Inc. for the previous quarter, Wall Street now forecasts 5.06% EPS growth.
Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage
Out of 9 analysts covering Nu Skin (NYSE:NUS), 3 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 33% are positive. Nu Skin has been the topic of 24 analyst reports since July 21, 2015 according to StockzIntelligence Inc. As per Friday, April 29, the company rating was maintained by Pivotal Research. The firm has “Sell” rating given on Thursday, August 13 by Zacks. Stifel Nicolaus maintained the shares of NUS in a report on Friday, April 29 with “Sell” rating. The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) has “Buy” rating given on Friday, August 7 by Deutsche Bank. The firm earned “Hold” rating on Wednesday, October 7 by Canaccord Genuity. On Wednesday, October 7 the stock rating was maintained by Pivotal Research with “Buy”. Citigroup maintained the stock with “Buy” rating in Tuesday, April 19 report. The rating was initiated by Jefferies with “Hold” on Friday, June 3. The rating was maintained by Citigroup with “Buy” on Thursday, September 15. The company was downgraded on Friday, February 12 by Sidoti.
Insitutional Activity: The institutional sentiment increased to 1.07 in Q2 2016. Its up 0.03, from 1.04 in 2016Q1. The ratio is positive, as 30 funds sold all Nu Skin Enterprises, Inc. shares owned while 60 reduced positions. 36 funds bought stakes while 60 increased positions. They now own 40.71 million shares or 5.55% less from 43.10 million shares in 2016Q1.
Moreover, Sprott has 0.24% invested in Nu Skin Enterprises, Inc. (NYSE:NUS) for 102,500 shares. Schwab Charles Investment Management, a California-based fund reported 248,446 shares. The Maryland-based Price T Rowe Associates Md has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS). Moreover, Miles Cap has 0.65% invested in Nu Skin Enterprises, Inc. (NYSE:NUS) for 20,626 shares. Moreover, California State Teachers Retirement System has 0.01% invested in Nu Skin Enterprises, Inc. (NYSE:NUS) for 118,734 shares. Dreman Value Mngmt L L C accumulated 306 shares or 0.01% of the stock. Aqr Management Limited Liability Company holds 0.09% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS) for 1.08 million shares. Fmr Llc has 0.03% invested in the company for 5.23 million shares. Checchi Advisers Limited Liability Com has 507 shares for 0% of their US portfolio. Spark Llc has 54,700 shares for 0.24% of their US portfolio. Robertson Opportunity Cap Ltd Co has invested 2.71% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). Royal Retail Bank Of Canada owns 41,424 shares or 0% of their US portfolio. Boston Prtnrs, a Massachusetts-based fund reported 485,227 shares. The Manitoba – Canada-based Ig Inv Management Limited has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS). Synovus Finance last reported 0% of its portfolio in the stock.
Insider Transactions: Since September 22, 2016, the stock had 0 insider purchases, and 1 insider sale for $1.92 million net activity. LIPMAN ANDREW D also sold $1.92 million worth of Nu Skin Enterprises, Inc. (NYSE:NUS) shares.
Nu Skin Enterprises, Inc. is a direct selling firm that develops and distributes personal care products and nutritional supplements, and a range of other services and products. The company has a market cap of $3.74 billion. The Firm offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. It has a 37.48 P/E ratio. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.